Pharmaceutical and Life Sciences Sector Task Force

On this page

About the task force

The Pharmaceutical and Life Sciences Sector Task Force is a joint federal initiative led by Health Canada and Innovation, Science and Economic Development Canada. The task force will:

The task force will bring together senior leaders and subject matter experts with deep experience in pharmaceuticals and life sciences. These leaders and experts will give advice and recommendations for improving access to medicines while continuing to support a strong and competitive pharmaceutical and life sciences industry in Canada.

The task force includes select members from:

Co-chair biographies

Martin LeBlanc

Martin is co-founder and Vice-Chairman of CellCarta Biosciences, after having served as CEO for over 16 years. Formerly known as Caprion Biosciences, the Montreal-based company is a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Martin also serves as a strategic advisor to 3 private equity funds, chairs the boards of directors of Icentia and Saguaro Biosciences, and sits on the boards of several other life sciences companies. Before co-founding Caprion, he was a management consultant for McKinsey & Company and led Advanced Bioconcept, which was acquired by NEN Life Sciences (now Revvity).

In a volunteer capacity, Martin has served on the Governing Council of the Canadian Institutes of Health Research and on the Health and Biosciences Strategy Tables of Innovation, Science and Economic Development Canada. He holds a bachelor's degree in economics from the Université de Moncton and bachelor's and master's degrees in philosophy, politics and economics at Oxford University, as a Rhodes scholar.

Michelle Boudreau

Michelle Boudreau has worked in community and hospital pharmacy and with the Government of Canada in health policy and health products regulation. Her various leadership positions include Associate Assistant Deputy Minister in the Health Policy Branch, Director General in program administration, pharmaceutical policy and health product regulation, and legal counsel to Health Canada. Michelle holds degrees in pharmacy and law.

Page details

2026-04-09